Video
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the new regulatory requirements for controlled substances are changing pharmacists' daily practice.
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the new regulatory requirements for controlled substances are changing pharmacists' daily practice.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria